T cell activation through the antigen receptor (TCR) requires sustained signalling from microclusters in the peripheral region of the immunological synapse (IS). The bioenergetics of such prolonged signaling have been linked to the redistribution of mitochondria to the IS. Here, we report that stomatin-like protein-2 (SLP-2) plays an important role in this process by bridging polarized mitochondria to these signaling TCR microclusters or signalosomes in the IS in a polymerized actin-dependent manner. In this way, SLP-2 helps to sustain TCR-dependent signalling and enhances T cell activation.
Summary
T cell activation through the antigen receptor (TCR) requires sustained signalling from microclusters in the peripheral region of the immunological synapse (IS). The bioenergetics of such prolonged signaling have been linked to the redistribution of mitochondria to the IS. Here, we report that stomatin-like protein-2 (SLP-2) plays an important role in this process by bridging polarized mitochondria to these signaling TCR microclusters or signalosomes in the IS in a polymerized actin-dependent manner. In this way, SLP-2 helps to sustain TCR-dependent signalling and enhances T cell activation.
Introduction

CD4
+ T cell activation involves the formation of a highly organized interface between the T cell and the antigen-presenting cell (APC) known as the IS [1] [2] [3] [4] . This process requires selective polarization of some surface and intracellular molecules to the IS-proximal pole 5 and of others to the antipodal pole of the T cell 6, 7 , in a cytoskeleton-dependent manner. Furthermore, T cell polarization is highly dynamic as illustrated, within the IS, by the early detection of signalling microclusters in the outer ring of the synapse 8 and their subsequent movement, as activation proceeds, to the centre of the synapse where they are internalized and destined to degradation 2, 3, 9 to ensure signal down-regulation 10 .
A picture on how TCR signalling orchestrates cytoskeletal reorganization and polarization of surface and intracellular molecules is rapidly emerging [11] [12] [13] . However, much less is known about translocation and anchoring of organelles during T cell polarization. Recently, two reports have nicely documented the redistribution of mitochondria during different states of T cell function. Specifically, mitochondria translocate to the IS during T cell activation 14 , but relocate to the uropod during T cell locomotion 15 . Such a dynamic partitioning of mitochondria may have important implications in assuring the bioenergetics required for sustained signaling which in turn is required for full T cell responses.
To identify novel components of the molecular machinery that "bridge" TCR signalosomes with the cytoskeleton and cellular organelles, we performed a proteomic analysis of lipid raft microdomains from T cells undergoing activation through their TCR. Such an approach identified stomatin-like protein 2 (SLP-2) (also known as STOML2 or EPB72), a finding corroborated by other groups 16, 17 . SLP-2 is a member of the highly conserved stomatin family of proteins whose homologs span from archae to humans and include stomatin, SLP-1, and SLP-3 [18] [19] [20] [21] [22] . SLP-2 shares a central SPFH (stomatin/prohibitin/flotillins/HflK-HflC) domain characteristic of this family that may mediate interactions with membrane proteins [23] [24] [25] .
However, SLP-2 is unique among stomatins in that it does not have a putative transmembrane domain, but has six myristoylation/palmitoylation sites and an N terminal mitochondria targeting sequence 25, 26 .
The function of stomatins, including SLP-2, is unknown. It has been suggested that they are involved in the organization of the peripheral cytoskeleton, and in the assembly of ion channels 25,27-30 and mechanosensation receptors [31] [32] [33] [34] [35] [36] [37] . Here, we report that SLP-2 provides a structural link between synapse-polarized mitochondria and TCR signalosomes, and thus contributes to modulate TCR signaling and T cell activation.
Results
To explore the involvement of SLP-2 in immune cell activation, we first looked at its expression within human hematopoietic organs and tissues. We detected SLP-2 mostly in lymph nodes and thymus, and in lower amount, in tonsils (figure 1A). Little expression was detected in spleen and resting peripheral blood leukocytes, and the differences were not due to protein loading as normalized by blotting with glyceraldehyde-3-phosphate dehydrogenase (GAPDH). In individuals in which SLP-2 was detectable in peripheral blood mononuclear cells, it was expressed by monocytes, and to less extent, by T and B lymphocytes (supplemental figure 1).
In lymph nodes, SLP-2 was mostly detected in the paracortical (T cell) area and in the germinal centres (B cell area) (figure 1B). In the thymus, SLP-2 expression was higher in the cortex than in the medulla (figure 1B). The higher expression of SLP-2 in sites where lymphocyte signaling and activation takes place (i.e., antigen activation in lymph nodes and tonsils, positive and negative selection in the thymus) prompted us to examine the effect of activation on SLP-2 expression. Although peripheral blood T cells express low levels or no SLP-2 under resting conditions, activation of these cells with bacterial superantigens led to a significant up-regulation of its expression ( figure 1C ). Similarly, in B cell preparations from human tonsils fractionated according to their activation status, SLP-2 was mostly detected in the fraction corresponding to activated memory (CD20 bright , CD27 + ) B cells ( figure 1D ). Seventy three percent of cells in this fraction (f1) were activated memory B cells (as indicated by expression of CD27), and only 8% of cells in this fraction were naïve B cells. In contrast, 60%
of the cells in fraction 4 were naïve B cells and only 11% were activated memory B cells.
Fractions 2 and 3 had progressively decreasing numbers of activated memory B cells (52% and 32%, respectively) and increasing numbers of naïve B cells (17% and 45% respectively).
Therefore, the profile of SLP-2 expression in these fractions correlated with the presence of activated memory B cells. Together these data led us to conclude that SLP-2 expression is upregulated by in vivo and ex vivo lymphocyte activation.
To define the role of SLP-2 in T cell activation, we next established its intracellular distribution in resting T cells and during activation with APC and the staphylococcal enterotoxin E (SEE) bacterial superantigen. In Jurkat T cells stably transfected with a doxycyclineinducible, green fluorescence protein (gfp)-tagged SLP-2 (SLP-2-gfp), we identified two pools of SLP-2. Most SLP-2 signal was detected in intracellular clusters distributed in a relatively even fashion throughout the cell. In addition, a second small but significant pool of SLP-2 was consistently detected in the periphery of the cytoplasm and appeared to be associated with the inner leaflet of the plasma membrane (figure 2A). Similar distribution was observed with indirect immunofluorescence of endogenous SLP-2 using an antiserum against SLP-2 (supplemental figure 2) . The presence of two pools of SLP-2 within T cells was also documented by immunoblotting of subcellular T cell fractions (supplemental figure 3 ).
Upon activation of these Jurkat T cells with APC and SEE, both pools of SLP-2 (plasma membrane-associated pool and intracellular pool) converged towards putative synapses, and coalesced into a major cluster close to the plasma membrane in the periphery of the IS and underneath the T cell-APC interface (figure 2B). Such a polarization of SLP-2 was observed in more than 60% of T cells and was not due to "nuclear exclusion" or non-specific redistribution of molecules to the IS as we 7 and others 6, 38 have shown for gfp-tagged signaling molecules (e.g., phosphodiesterase 4B2). Next, we examined the redistribution of SLP-2 once it had relocated to the IS. We found that, after polarizing to the T cell:APC interface, more than 80%
of the polarized SLP-2-gfp partitioned in the periphery of the synapse and underneath the IS as activation proceeded, and only a small fraction of SLP-2 was detectable in the centre of the IS where downregulated TCR clusters are (figure 2C and supplementary video 1).
The polarization of SLP-2 during T cell activation was examined in more detail using supported planar bilayers containing anti-CD3 and ICAM-1 to which T cells form IS-like structures (figure 3 and supplementary videos 2A and 2B). This system has excellent optics for resolution of components in the IS. With this system, and under conditions of doxycyclineinduced SLP-2-gfp overexpression, we confirmed the presence of two pools of SLP-2. The plasma membrane-associated pool of SLP-2 was visualized by total internal reflection fluorescence microscopy (TIRFM) as weak but consistent signal clusters located at less than 200nm from the glass plane (i.e., sites of TCR and LFA-1 engagement) ( figure 3A ). In the early or nascent IS, this pool of SLP-2 was distributed in a uniform granular appearance with TCR microclusters (figure 3A top row). However, as activation proceeded, we observed a reduction of SLP-2 fluorescence in the TCR microclusters as these relocated to the centre of the IS (up to 50% reduction) (figure 3A bottom row), while densely packed SLP-2 clusters were still observed in the periphery of the IS. It is important to note that the TCR clusters at the centre of the synapse have been identified as not-signaling clusters any more but as TCR oligomers destined to internalization and degradation.
The major pool of SLP-2-gfp, located at more than 200 nm from the plasma membrane, also polarized to the IS and distributed close to the pSMACs, segregated from the cSMACs, as activation proceeded (figure 3B, supplementary video 2A, and Table 1 ). This major pool of SLP-2 within the cell was identified as associated with mitochondria as shown by the co-localization of the gfp signal with a mitochondria-targeted red fluorescence protein (mtRFP) ( figure 3C ). Of interest, such a polarization of mitochondria to the IS has been recently confirmed by another group 14 .
The polarization of SLP-2 to the IS and its peripheral distribution once in the synapse required TCR engagement because, as determined by wide field fluorescence microscopy, it was observed in 100% of the cells forming an IS in response to TCR/LFA-1 co-ligation but in none of the cells responding to LFA-1 ligation alone ( Table 2 , and supplementary videos 2A and 2B).
The distribution of SLP-2 during T cell activation was stable as shown by fluorescence recovery after photobleaching (FRAP) (figure 4 and supplementary videos 3A and 3B). In these experiments, the SLP-2 signal was restored after 400 seconds of bleaching the plasma membrane of non-stimulated T cells but was not restored when SLP-2-gfp clusters in OKT3-stimulated T cells were bleached within the same timeline. Furthermore, we documented that SLP-2 was detected in lipid rafts and its partitioning to these microdomains increased during T cell activation (supplemental figure 4) . suggesting that SLP-2/PLC-1 complexes may be preassembled before TCR signalling.
During synapse formation, LFA-1 is organized in microclusters in the pSMAC. In this area, LFA-1 microclusters are interspersed with TCR microclusters 9 . As predicted by the location of SLP-2 in the periphery of the IS, we found that, upon activation with SEE and APC, there was a rapid increase in the level of association of SLP-2 with LFA-1 that decreased at later time points of activation (figure 5B).
It is important to note that all the co-precipitation studies reported above were performed under high stringency condition with strong detergents (Triton X-100 1%). Also, under these conditions, we detected selective interactions of SLP-2 with only some receptors and signaling molecules but not with other molecules (e.g., CD45, CTLA-4, RasGAP, caspase 3).
Since TCR signaling leads to cytoskeletal reorganization, and since the cytoskeleton is required for intracellular movement of mitochondria, we predicted that the association of SLP-2 with the TCR signalosome and with mitochondria during T cell activation would involve the cytoskeleton. To test this idea, we examined the interaction of SLP-2 with actin. We found that SLP-2 interacted with actin under resting conditions and upon TCR stimulation ( figure 5C ).
SLP-2 also interacted with vav, a small GTPase that regulates cytoskeletal reorganization, and with Nck, an adaptor protein that links transmembrane and scaffolding molecules to the cytoskeleton 41 (and this interaction peaked at the times of maximal interaction between SLP-2 and the components of the signalosome) ( figure 5C ). The association between SLP-2 and cytoskeletal molecules was not observed using a control pre-immune serum, ruling out a nonspecific association. Furthermore, the association between SLP-2 and -actin during T cell activation involved the polymerized form of actin because cytochalasin D, an inhibitor of actin polymerization, completely prevented this interaction ( figure 5D ). It is important to note that T cell activation in our system is dependent on actin polymerization, because inhibition of actin polymerization led to inhibition of IL-2 production ( figure 5D ).
Next, we examined the biological implications of the interactions between SLP-2 and the components of the TCR signalosome. We reasoned that, if SLP-2 was required for signaling from the TCR signalosomes, then knocking down SLP-2 would decrease TCR signalling. To test this hypothesis, we knocked down SLP-2 expression by RNA interference using two different sets of siRNAs. We found that the effect of SLP-2 down-regulation on IS formation was minimal (although statistically significant over multiple experiments) (figure 6A .
Material and methods
Plasmids, siRNA and T cell transfectants. Human SLP-2 cDNA was subcloned into the pEGFP- Antibodies. An antiserum against human SLP-2 was generated by immunization of rabbits with a peptide spanning amino acids 343 to 356 (ProSci Inc., Poway, CA). Commercially available antibodies against SLP-2 were purchased from Protein Tech Group (Chicago, IL).
Immunoblotting for ERK-1/2 was done using a rabbit polyclonal immunoaffinity purified antiserum (Stressgen Biotechnologies, Victoria, BC, Canada). Actin was immunoblotted using an affinity-purified goat polyclonal antiserum (Santa Cruz Biotechnology Inc., Santa Cruz, CA).
CD45 was immunoblotted using a mouse monoclonal (clone 69) antibody (BD Biosciences, Mississauga, ON, CA). Lck and Nck were immunoblotted using rabbit antisera (Upstate Biotechnology, Lake Placid, NY). Isotype control immunoprecipitations were performed using pre-immune serum obtained from ProSci. A pre-immunization serum was used as control for rabbit antisera (ProSci Inc., Poway, CA). Immunoprecipitation of SLP-2 was performed with our SLP-2 antibodies (Prosci, Poway, CA). For confocal microscopy a PE-labelled anti-CD3
(UCHT-I) was used.
Sub-Cellular Fractionation, and Raft isolation. Subcellular T cell compartments were obtained using the Compartmental Protein Extraction Kit (Chemicon, Temecula, CA). Lipid rafts were isolated by sucrose gradient ultracentrifugation following lysis with 0.5% Triton-X-100 as described 56 . Lipid rafts were pelleted by centrifugation of the 1mL raft fraction for 1 hour at 14,000 rpm and 4°C, and were resuspended in lysis buffer and sample buffer for biochemical analysis.
Cell lysates preparation. Jurkat T cells were stimulated with superantigens at final concentration of 1ug/ml, at 37ºC, for 1, 5, 15, 30 and 60 min. Cells were pelleted in PBS containing sodium ovanadate (400uM) and EDTA (400uM) and lysed in lysis buffer (1% Triton X-100, 150mM
NaCl, 10mM Tris (pH7.6), 5mM EDTA, 1mM sodium o-vanadate, 10ug/ml leupeptin, 10ug/ml aprotinin, 25uM p-nitrophenyl-p'-guanidinobenzoate) at 4ºC for 30min. Lysates were cleared of debris (14,000rpm, 4ºC, 10min) followed by immunoprecipitation of target molecules using Abcoated protein A or G agarose beads. Confocal microscopy. Confocal microscopy was performed with a Zeiss LSM 510 microscope.
Jurkat T cells (1x10 6 /ml), were incubated on poly-lysine-coated (0.01%, Sigma) glass bottom microwell dishes (MatTek Corp., MA) for 10 minutes to promote cell adherence at 37ºC. SLP-2-gfp distribution during IS formation was assessed by culturing doxycycline-induced SLP-2-gfp stably transfected T cells with APCs pre-incubated with 1000 ng/ml SEE for either 10 or 30 minutes. Following the allotted time of co-incubation, the T cell-APC conjugates were rapidly fixed with paraformaldehyde (4% paraformaldehyde) and washed with PBS/1% FCS and stained with PE conjugated anti-CD3 (BD Bioscience, Mississauga, ON,CA) for 30 min. on ice. For experiments using planar membranes, glass-supported dioleoylphosphatidylcholine bilayers incorporating Cy5-ICAM-1 (300 molecules/μm 2 ) and 0.1% cap-biotin were prepared in a Bioptechs flow cell. Unlabelled Streptavidin (8 μg/mL) and anti-human CD3, OKT3 clone (10 μg/mL), which was conjugated to Cy3, were loaded sequentially in HBS/HSA buffer. Jurkat T cells were suspended in Hepes buffered saline supplemented with 5 mM glucose, 2 mM MgCl 2 , 1 mM CaCl 2 , and 1% human serum albumin (HBS/HSA). All wide field microscopy was performed on an automated microscope with a Hamamatsu USA Orca-ER cooled CCD camera.
The hardware on the microscope was controlled using IPLAB software (Scanalytics) on a PowerMac G4 Macintosh computer. Images were exposed in wide field for 1-2 s at a resolution of 0.11 μm per pixel using the 60x ***
TABLES
